CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $37,028
- in 8 filings
Net −$37,028. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blume-Jensen Peter −$34K President and CEO sold 4% of stake
- Miller Mary −$2K Chief Legal Officer sold 1% of stake
- Devroe Eric −$911 Chief Operating Officer sold <1% of stake
- Gamelin Erick −$603 Chief Development Officer sold <1% of stake
- Peterson Katharine −$155 Chief Accounting Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Levin Michaela Chief Business Officer | Grant or award | +30,000 | 30,000 | ||
| 2026-08-31 | Levin Michaela Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 |
Page 1 of 1 · 2 trades